UT Southwestern/Simmons Cancer Center-Dallas — Dallas, Texas

UT Southwestern/Simmons Cancer Center-Dallas is a clinical research site located in Dallas, Texas, United States 75390.

Crixeo Clinical Trials Trust Score: 35/100 (FAILING). This profile has not yet been claimed by the site owner.

UT Southwestern/Simmons Cancer Center-Dallas has participated in 473 clinical trials with 274 currently active.

Therapeutic areas: B Acute Lymphoblastic Leukemia, Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Hodgkin Lymphoma.

Sponsors: National Cancer Institute (NCI), Children's Oncology Group, NRG Oncology.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Dallas

Browse all research sites in Texas · View every site in Dallas

Sponsor Feasibility Report

Trust Score: 35/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UT Southwestern/Simmons Cancer Center-Dallas?

UT Southwestern/Simmons Cancer Center-Dallas has a Crixeo Trust Score of 35/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UT Southwestern/Simmons Cancer Center-Dallas conducted?

UT Southwestern/Simmons Cancer Center-Dallas has 473 clinical trials on record, with 274 currently active. Their work covers B Acute Lymphoblastic Leukemia, Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Hodgkin Lymphoma.

Is UT Southwestern/Simmons Cancer Center-Dallas accredited by Crixeo Clinical Trials?

UT Southwestern/Simmons Cancer Center-Dallas has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UT Southwestern/Simmons Cancer Center-Dallas?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.